• Explore /
  • Poster
  • / A phase I trial of cixutumumab (C) (IMC-A12) and sorafenib (S) for treatment of advanced hepatocellular carcinoma (HCC).

A phase I trial of cixutumumab (C) (IMC-A12) and sorafenib (S) for treatment of advanced hepatocellular carcinoma (HCC).

Abstract Poster

Authors

null

Anthony B. El-Khoueiry

USC Norris Comprehensive Cancer Center, Los Angeles, CA

Anthony B. El-Khoueiry , Robert O'Donnell , Philip C Mack , Suzette Blanchard , Nathan Bahary , Yixing Jiang , Yun Yen , John Joseph Wright , Helen Chen , Heinz-Josef Lenz , David R. Gandara

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT01008566

Citation

J Clin Oncol 32, 2014 (suppl 3; abstr 293)

DOI

10.1200/jco.2014.32.3_suppl.293

Abstract #

293

Poster Bd #

C8

Abstract Disclosures

Similar Posters

First Author: Anthony B. El-Khoueiry

First Author: Changhoon Yoo

First Author: R. S. Finn

Poster

2019 Gastrointestinal Cancers Symposium

Phase I study of tramatinib combined with sorafenib in patients (pts) with advanced hepatocellular cancer (HCC).

Phase I study of tramatinib combined with sorafenib in patients (pts) with advanced hepatocellular cancer (HCC).

First Author: Emilie Wang